Minerva Neurosciences (NERV) Current Assets (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Current Assets data on file, last reported at $79.1 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 341.32% year-over-year to $79.1 million; the trailing twelve-month figure through Mar 2026 stood at $79.1 million (up 341.32% YoY), and the FY2025 full-year result was $83.1 million, up 273.16% from the prior year.
• Current Assets for Q1 2026 stood at $79.1 million, down from $83.1 million in the prior quarter.
• Across five years, Current Assets topped out at $83.1 million in Q4 2025 and bottomed at $13.0 million in Q3 2025.
• The 5-year median for Current Assets is $40.2 million (2022), against an average of $40.9 million.
• The widest annual swing landed in 2025, when Current Assets plunged 53.39%; it then jumped 341.32% in 2026.
• A 5-year view of Current Assets shows it stood at $40.2 million in 2022, then advanced by 4.59% to $42.0 million in 2023, then sank by 46.98% to $22.3 million in 2024, then jumped by 273.16% to $83.1 million in 2025, then dropped by 4.8% to $79.1 million in 2026.
• The last three Current Assets figures came in at $79.1 million (Q1 2026), $83.1 million (Q4 2025), and $13.0 million (Q3 2025), per Business Quant data.

Peer Comparison